Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.1K citations · Full text

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros et al. · Cell · 2020 · 2K citations · Full text

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Julian Braun, Lucie Loyal, Marco Frentsch et al. · Nature · 2020 · 1.4K citations · Full text

Long Covid, Covid-19 Pandemic, Immunology +3

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Katharina Röltgen, Abigail E. Powell, Oliver F. Wirz et al. · Science Immunology · 2020 · 501 citations · Full text

Vaccination, Longitudinal Plasma Samples, Sars-cov-2 Infection +14

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

Adrian Shields, Siobhan O. Burns, Sinisa Savic et al. · Journal of Allergy and Clinical Immunology · 2020 · 234 citations · Full text

Primary Immunodeficiency, Secondary Immunodeficiency, United Kingdom Experience +7